Table 7

Outcomes predicted by models for one birth cohort in Afr-region

POLYMODa

Roxanne

CoRoVa


Undiscounted cases

Mild

92,989

121,312

128,807

Moderate

49,051

70,126

54,559

Severe

5,092

9,589

5,277

Nosocomial

1,680

1,986

2,701

Deaths

955

1,789

1,524

Outpatient

54,143

70,126

54,559

Inpatient (comm. acq.)

5,092

9,589

5,277

Discounted savings

Outpatient

$568,502

$716,305

$623,977

Inpatient

$973,247

$1,329,538

$753,884

Indirect

$108,916

$106,377

$81,486

Discounted net costsb (*1000)

$6,759

$ 8,757-17,094

$ 9,250-17,467

Discounted QALYs

Mortality

24,962

45,817

39,070

Morbidity

542

762

628


a. Approximation for one cohort from the multi-cohort results; b. Health-care perspective and range given for previous upper and lower vaccine prices if appropriate.

Postma et al. BMC Medicine 2011 9:84   doi:10.1186/1741-7015-9-84

Open Data